Angiotensin II and TGF-β1 Induce Alterations in Human Amniotic Fluid-Derived Mesenchymal Stem Cells Leading to Cardiomyogenic Differentiation Initiation

BACKGROUND AND OBJECTIVES: Human amniotic fluid-derived mesenchymal stem cells (AF-MSCs) may be a valuable source for cardiovascular tissue engineering and cell therapy. The aim of this study is to verify angiotensin II and transforming growth factor-beta 1 (TGF-β1) as potential cardiomyogenic diffe...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Stem Cells
Glavni autori: Gasiūnienė, Monika, Petkus, Gintautas, Matuzevičius, Dalius, Navakauskas, Dalius, Navakauskienė, Rūta
Format: Artigo
Jezik:Inglês
Izdano: Korean Society for Stem Cell Research 2019
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6657950/
https://ncbi.nlm.nih.gov/pubmed/31023001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15283/ijsc18126
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items